References
- Sternbach LH, Randall LO, Banziger R, et al. Structure–activity relationships in the 1,4-benzodiazepine series. In: Burger A, editor. Drugs affecting the central nervous system. vol. 2. London: Edward Arnold; 1968. 237 p.
- Gray NM, Cheng BK. Preparation of 1,2 diarethylamines for treatment of neurotoxic injury. EU patent no. EP346791A1. 2016.
- Moosmann B, Huppertz LM, Hutter M, et al. Detection and identification of the designer benzodiazepine flubromazepam and preliminary data on its metabolism and pharmacokinetics. J Mass Spectrom. 2013;48:1150–1159.
- Wallach J, Kang H, Colestock T. Pharmacological investigations of the dissociative “legal highs” diphenidine, methoxphenidine and analogues. PLoS One. 2016;11:e0157021.
- Helander A, Beck O, Backberg M. Intoxications by the new dissociative psychoactive substances diphenidine and methoxphenidine. Clin Toxicol. 2015;53:446–453.
- Hofer KE, Degrandi C, Müller DM, et al. Acute toxicity associated with the recreational use of the novel dissociative psychoactive substance methoxphenidine. Clin Toxicol. 2014;52:1288–1291.